EDN1 and Alzheimer disease: Palmer et al. revealed that ET-1 levels are elevated in AD and are upregulated by amyloid β (Aβ); they also demonstrated that endothelin-converting enzyme-2 (ECE-2) is upregulated by Aβ, and its expression is elevated in AD post-mortem brain tissue when compared with controls [15].